Latest Regulatory Approvals News

RUA GOLD has obtained regulatory approval to start exploration drilling at its Glamorgan Project, a promising epithermal gold target adjacent to a major OceanaGold deposit in New Zealand. The company plans a 9,000-metre drill program to test three high-priority targets identified through extensive geophysical and geochemical surveys.

Pinnacle Investment Management delivered a 31.5% jump in net profit after tax to $176.7 million for FY26, boosted by full ownership of Pacific Asset Management and strong inflows across retail, institutional, and international channels.

WA Gold's latest assays from seven diamond drill holes at Abercromby reinforce the continuity of a high-grade gold system over 500m, underpinning a promising resource development phase.

CurveBeam AI has launched a Share Purchase Plan offering eligible shareholders a 10% discount on new shares, aiming to raise up to $2 million alongside a pending $5 million placement.

Neurotech International has secured $4.5 million through a share placement to fund its pivotal Phase III clinical trial of NTI164 for Autism Spectrum Disorder, aiming to reach topline data readout.

Lumos Diagnostics has landed a US$767,800 purchase order for its FebriDx rapid test from PHASE Scientific, marking a key step in commercialising its FDA-approved product ahead of the US flu season.

Aldoro Resources has boosted the Kameelburg rare earth project’s Mineral Resource Estimate to 804.5 million tonnes, now hosting 1.37 million tonnes of contained NdPr oxide; exceeding key western-world deposits. The maiden Indicated Resource and robust metallurgical testwork set the stage for development.

Tusker Minerals has inked a binding deal to sell its Machinga Rare Earth Elements project in Malawi to AuKing Mining for up to A$4 million, freeing capital to concentrate on its high-grade rutile and heavy mineral sands assets.

Control Bionics has achieved FDA registration for its NeuroStrip surface EMG platform, cementing its medical device status in the US and bolstering its appeal in clinical and research markets.

AuKing Mining has agreed to acquire 100% of the Machinga Heavy Rare Earths Project in Malawi, adding a high-grade heavy rare earth and niobium asset to its portfolio. The acquisition includes a mix of cash, shares, and performance shares contingent on resource milestones, positioning AuKing to accelerate exploration in a geopolitically strategic region.

Vitrafy Life Sciences reported an 80% revenue surge and halved its net loss, buoyed by US military validation and major blood network partnerships. A $32 million capital raise fuels its US commercial expansion and manufacturing scale-up.

Global Lithium Resources has secured the Mining Development and Closure Proposal approval for its Manna Lithium Project, paving the way for early works and infrastructure development ahead of a planned Final Investment Decision in late 2026.